Langabeer, S., Haslam, K., Crampe, M., MacDonagh, B., & McHugh, J. (2023). Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia. Experimental Oncology, 41(1), 82–83. https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12685